ZELREVV
LIVE

Serial Number

99727445

Owner

Amgen Inc.

Attorney

Elsa D. Lemoine

Filing Date

Mar 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ZELREVV Trademark

Serial Number: 99727445

ZELREVV is a trademark filed by Amgen Inc. on March 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Amgen Inc. (17 trademarks)

One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Entity Type: 03

Trademark Details

Filing Date

March 26, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer; Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders; Pharmaceutical preparations for use in the treatment of metastatic diseases; Pharmaceutical preparations for treating metabolic diseases and disorders; Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders; Pharmaceutical preparations

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 18, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 18, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2026 CNRT
ASSIGNED TO EXAMINER
May 14, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 26, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2026 NWOS
NEW APPLICATION ENTERED
Mar 26, 2026 NWAP